PeptideDB

CDK-IN-16

CDK-IN-16

CAS No.:

CDK-IN-16 (Compound 5g) is a CDK2/cyclin A2 inhibitor with IC50 of 1.67 μM. CDK-IN-16 has anticancer activity. The IC50
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

CDK-IN-16 (Compound 5g) is a CDK2/cyclin A2 inhibitor with IC50 of 1.67 μM. CDK-IN-16 has anticancer activity. The IC50 of CDK-IN-16 against AGS cell line is 3.5 μM.

Physicochemical Properties


Molecular Formula C23H17N3O
Molecular Weight 351.40
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


References

[1]. Novel Fused Pyrimidines as Potent Cyclin-Dependent Kinases Inhibitor for Gastric Adenocarcinoma: Combined In Vitro, In Silico Anticancer Studies. Chem Biol Drug Des. 2024 Nov;104(5):e70013.


Solubility Data


Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.8458 mL 14.2288 mL 28.4576 mL
5 mM 0.5692 mL 2.8458 mL 5.6915 mL
10 mM 0.2846 mL 1.4229 mL 2.8458 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.